or Try an Advanced Search...

    Disorders Stocks List

    Symbol Grade Name % Change
    ITCI A Intra-Cellular Therapies Inc. -1.11
    DXR A Daxor Corporation 1.22
    ELDN A Eledon Pharmaceuticals, Inc. -2.78
    ELYM B Eliem Therapeutics, Inc 1.33
    IBIO B iBio, Inc. -2.63
    NBIX B Neurocrine Biosciences, Inc. -0.71
    IGC B India Globalization Capital Inc. -8.67
    CGTX B Cognition Therapeutics, Inc. -0.50
    VTGN B VistaGen Therapeutics, Inc. -2.51
    CPRX B Catalyst Pharmaceutical Partners, Inc. 2.58
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Biopharmaceutical Epilepsy Medicine Alzheimer's Disease Health Sciences Major Depressive Disorder Pain Parkinson's Disease Psychiatric Diagnosis Aging Associated Diseases Biotechnology Clinical Development Cognitive Disorders Dementia Depressive Disorder Insomnia Medication Mental Health Neuroscience Pharmaceutical

    Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 13.38
    PBE D PowerShares Dynamic Biotech & Genome 10.96
    FBT D First Trust Amex Biotech Index Fund 7.75
    BBP F BioShares Biotechnology Products Fund 4.82
    XPH D SPDR S&P Pharmaceuticals ETF 4.74
    View all Disorders ETFs...
    Compare ETFs
    Compare FBT to BBP Compare FBT to XPH Compare PBE to FBT

        Disorders Stocks Recent News

        Date Stock Title
        Apr 23 NBIX Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug
        Apr 23 NBIX No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
        Apr 23 NBIX Neurocrine scores surprise win with depression drug
        Apr 23 NBIX Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
        Apr 22 NBIX 10 Best Performing Biotech ETFs in 2024
        Apr 22 ITCI 10 Best Performing Biotech ETFs in 2024
        Apr 22 CPRX Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
        Apr 22 CGTX Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease
        Apr 19 ITCI How Is The Market Feeling About Intra-Cellular Therapies?
        Apr 18 CGTX Cognition Therapeutics: Approaching Phase 2 Readout In Alzheimer's
        Apr 18 CPRX Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
        Apr 18 ITCI Intra-Cellular Therapies drops 2%, prices $500M equity financing
        Apr 18 ITCI Intra-Cellular Therapies Prices Public Offering of Common Stock
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Biopharmaceutical Epilepsy Medicine Alzheimer's Disease Health Sciences Major Depressive Disorder Pain Parkinson's Disease Psychiatric Diagnosis Aging Associated Diseases Biotechnology Clinical Development Cognitive Disorders Dementia Depressive Disorder Insomnia Medication Mental Health Neuroscience Pharmaceutical
        Disorders

        Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

        More about Disorders
        Browse All Tags